Approval · Notice of Compliance 22653 · 2019
GENTAMICIN(E): Notice of Compliance 22653
Issued September 13, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22653
- Date
- September 13, 2019
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- To update labels to align with Plain Language Labelling Guidelines
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GENTAMICIN(E) | Not yet assigned | — |
Medicinal ingredients
- GENTAMICIN 1 MG per ML
- GENTAMICIN 1.6 MG per ML